Anirban Maitra
Anirban Maitra is a pancreatic cancer pathologist working on catching the disease early and understanding its precursors.
Anirban Maitra is a pathologist and pancreatic cancer researcher. Maitra leads early-detection efforts including the pancreatic cancer risk and cyst programmes, and studies the biology of pancreatic precursor lesions and KRAS-driven tumorigenesis.
| Title | Journal | Year |
|---|---|---|
| Early Detection of Pancreatic Cancer: Opportunities and Challenges | Gastroenterology | 2019 |
| Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray | Modern Pathology | 2003 |
Pages like this
not linked directly; found by shared links- PersonAlbert C. Koong
Shares MD Anderson Cancer Center, Pancreatic ductal adenocarcinoma.
- PersonPeter W. T. Pisters
Shares MD Anderson Cancer Center, Pancreatic ductal adenocarcinoma.
- TechnologyEngineered exosomes as drug carriers
Shares MD Anderson Cancer Center, KRAS, Pancreatic ductal adenocarcinoma.
- PersonBert Vogelstein
Shares Multi-cancer early detection (MCED), KRAS, Liquid biopsy (ctDNA), Pancreatic ductal adenocarcinoma.
- IdeaCheap DNA fragment-pattern blood test as a first sieve before expensive cancer tests
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
- IdeaA guaranteed purchase prize for the first drug against a named hard target
Shares KRAS, Pancreatic ductal adenocarcinoma.
- PersonJohn V. Heymach
Shares MD Anderson Cancer Center, KRAS.
- PairingG12D-selective + pan-RAS(ON) inhibitor (zoldonrasib + daraxonrasib)
Shares KRAS, Pancreatic ductal adenocarcinoma.